Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein
Hong Chen,1–3,* Huizi Sha,2,* Lianru Zhang,2 Hanqing Qian,2 Fangjun Chen,2 Naiqin Ding,2 Liulian Ji,2 Anqing Zhu,2 Qiuping Xu,2 Fanyan Meng,2 Lixia Yu,2 Yan Zhou,3 Baorui Liu1,2 1The Comprehensive Cancer Centre, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, N...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/780e8cf9d6d4416b89dad9f068e23361 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:780e8cf9d6d4416b89dad9f068e23361 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:780e8cf9d6d4416b89dad9f068e233612021-12-02T07:24:17ZLipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein1178-2013https://doaj.org/article/780e8cf9d6d4416b89dad9f068e233612018-09-01T00:00:00Zhttps://www.dovepress.com/lipid-insertion-enables-targeted-functionalization-of-paclitaxel-loade-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Hong Chen,1–3,* Huizi Sha,2,* Lianru Zhang,2 Hanqing Qian,2 Fangjun Chen,2 Naiqin Ding,2 Liulian Ji,2 Anqing Zhu,2 Qiuping Xu,2 Fanyan Meng,2 Lixia Yu,2 Yan Zhou,3 Baorui Liu1,2 1The Comprehensive Cancer Centre, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, People’s Republic of China; 2The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of China; 3Department of Oncology, Yixing People’s Hospital, Jiangsu, People’s Republic of China *These authors contributed equally to this work Background: There is currently much interest in cancer cell targeting and tumor penetrating for research and therapeutic purposes.Purpose: To improve targeting delivery of antitumor drugs to gastric cancer, in this study, a tumor-targeting biocompatible drug delivery system derived from erythrocyte membrane for delivering paclitaxel (PTX) was constructed.Methods: Erythrocyte membrane of human red blood cells (RBCs) were used for preparing of erythrocyte membrane-derived vesicles. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(maleimide[polyethylene glycol]-3400) (DSPE-PEG-MAL), a phospholipid derivative, was used to insert tumor-targeting molecular into erythrocyte membrane-derived vesicles. A lipid insertion method was used to functionalize these vesicles without the need for direct chemical conjugation. Furthermore, a tumor-penetrating bispecific recombinant protein named anti-EGFR-iRGD was used for the first time in this work to enable nanosystem to target and penetrate efficiently into the tumor site.Results: Paclitaxel (PTX)-loaded anti-EGFR-iRGD-modified erythrocyte membrane nanosystem (anti-EGFR-iRGD-RBCm-PTX, abbreviated to PRP) were manufactured. PRP was spheroid, uniformly size, about 171.7±4.7 nm in average, could be stable in vitro for 8 days, and released PTX in a biphasic pattern. PRP showed comparable cytotoxicity toward human gastric cancer cells in vitro. In vivo studies showed that, PRP accumulated in tumor site within 2 h of administration, lasted longer than 48 h, and the tumor volume was reduced 61% by PRP treatment in Balb/c nude mice, without causing severe side effects.Conclusion: PRP has potential applications in cancer treatment and as an adjunct for other anticancer strategies. Keywords: tumor-penetrating bispecific recombinant protein, erythrocyte membrane, biomimetic nanoparticle, drug deliveryChen HSha HZhang LQian HChen FDing NJi LZhu AXu QMeng FYu LZhou YLiu BDove Medical PressarticleTumor-penetrating bispecific recombinant proteinErythrocyte membraneBiomimetic nanoparticleDrug delivery;Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 5347-5359 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Tumor-penetrating bispecific recombinant protein Erythrocyte membrane Biomimetic nanoparticle Drug delivery; Medicine (General) R5-920 |
| spellingShingle |
Tumor-penetrating bispecific recombinant protein Erythrocyte membrane Biomimetic nanoparticle Drug delivery; Medicine (General) R5-920 Chen H Sha H Zhang L Qian H Chen F Ding N Ji L Zhu A Xu Q Meng F Yu L Zhou Y Liu B Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein |
| description |
Hong Chen,1–3,* Huizi Sha,2,* Lianru Zhang,2 Hanqing Qian,2 Fangjun Chen,2 Naiqin Ding,2 Liulian Ji,2 Anqing Zhu,2 Qiuping Xu,2 Fanyan Meng,2 Lixia Yu,2 Yan Zhou,3 Baorui Liu1,2 1The Comprehensive Cancer Centre, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, People’s Republic of China; 2The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, People’s Republic of China; 3Department of Oncology, Yixing People’s Hospital, Jiangsu, People’s Republic of China *These authors contributed equally to this work Background: There is currently much interest in cancer cell targeting and tumor penetrating for research and therapeutic purposes.Purpose: To improve targeting delivery of antitumor drugs to gastric cancer, in this study, a tumor-targeting biocompatible drug delivery system derived from erythrocyte membrane for delivering paclitaxel (PTX) was constructed.Methods: Erythrocyte membrane of human red blood cells (RBCs) were used for preparing of erythrocyte membrane-derived vesicles. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(maleimide[polyethylene glycol]-3400) (DSPE-PEG-MAL), a phospholipid derivative, was used to insert tumor-targeting molecular into erythrocyte membrane-derived vesicles. A lipid insertion method was used to functionalize these vesicles without the need for direct chemical conjugation. Furthermore, a tumor-penetrating bispecific recombinant protein named anti-EGFR-iRGD was used for the first time in this work to enable nanosystem to target and penetrate efficiently into the tumor site.Results: Paclitaxel (PTX)-loaded anti-EGFR-iRGD-modified erythrocyte membrane nanosystem (anti-EGFR-iRGD-RBCm-PTX, abbreviated to PRP) were manufactured. PRP was spheroid, uniformly size, about 171.7±4.7 nm in average, could be stable in vitro for 8 days, and released PTX in a biphasic pattern. PRP showed comparable cytotoxicity toward human gastric cancer cells in vitro. In vivo studies showed that, PRP accumulated in tumor site within 2 h of administration, lasted longer than 48 h, and the tumor volume was reduced 61% by PRP treatment in Balb/c nude mice, without causing severe side effects.Conclusion: PRP has potential applications in cancer treatment and as an adjunct for other anticancer strategies. Keywords: tumor-penetrating bispecific recombinant protein, erythrocyte membrane, biomimetic nanoparticle, drug delivery |
| format |
article |
| author |
Chen H Sha H Zhang L Qian H Chen F Ding N Ji L Zhu A Xu Q Meng F Yu L Zhou Y Liu B |
| author_facet |
Chen H Sha H Zhang L Qian H Chen F Ding N Ji L Zhu A Xu Q Meng F Yu L Zhou Y Liu B |
| author_sort |
Chen H |
| title |
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein |
| title_short |
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein |
| title_full |
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein |
| title_fullStr |
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein |
| title_full_unstemmed |
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein |
| title_sort |
lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein |
| publisher |
Dove Medical Press |
| publishDate |
2018 |
| url |
https://doaj.org/article/780e8cf9d6d4416b89dad9f068e23361 |
| work_keys_str_mv |
AT chenh lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT shah lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT zhangl lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT qianh lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT chenf lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT dingn lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT jil lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT zhua lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT xuq lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT mengf lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT yul lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT zhouy lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein AT liub lipidinsertionenablestargetedfunctionalizationofpaclitaxelloadederythrocytemembranenanosystembytumorpenetratingbispecificrecombinantprotein |
| _version_ |
1718399462653558784 |